Pharmacologically Diverse Antidepressants Rapidly Activate Brain-Derived Neurotrophic Factor Receptor TrkB and Induce Phospholipase-Cγ Signaling Pathways in Mouse Brain
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Previous studies suggest that brain-derived neurotrophic factor and its receptor TrkB are critically involved in the therapeutic actions of antidepressant drugs. We have previously shown that the antidepressants imipramine and fluoxetine produce a rapid autophosphorylation of TrkB in the rodent brain. In the present study, we have further examined the biochemical and functional characteristics of antidepressant-induced TrkB activation in vivo. We show that all the antidepressants examined, including inhibitors of monoamine transporters and metabolism, activate TrkB rapidly in the rodent anterior cingulate cortex and hippocampus. Furthermore, the results indicate that acute and long-term antidepressant treatments induce TrkB-mediated activation of phospholipase-Cgamma1 (PLCgamma1) and increase the phosphorylation of cAMP-related element binding protein, a major transcription factor mediating neuronal plasticity. In contrast, we have not observed any modulation of the phosphorylation of TrkB Shc binding site, phosphorylation of mitogen-activated protein kinase or AKT by antidepressants. We also show that in the forced swim test, the behavioral effects of specific serotonergic antidepressant citalopram, but not those of the specific noradrenergic antidepressant reboxetine, are crucially dependent on TrkB signaling. Finally, brain monoamines seem to be critical mediators of antidepressant-induced TrkB activation, as antidepressants reboxetine and citalopram do not produce TrkB ac…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research on the biological connections demonstrated that antidepressants activate the BDNF via tropomyosin receptor kinase B (TrkB) and a common transcription factor cAMP response element-binding protein (CREB; Koponen et al., 2005;Rantamaki et al., 2007).”
From Serotonin and neuroplasticity – Links between molecular, functional and structural pathophysiology in depression (2017) · cites this paper as Rantamaki et al., 2007
In the citing paper
“Antidepressant drugs require functional TrkB receptors to mediate antidepressant-like response in preclinical models (Rantamäki et al., 2007; Saarelainen et al., 2003).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Rantamäki et al., 2007
In the citing paper
“Rather intriguingly, chronic antidepressant treatment increases the phosphorylation of the TrkB receptor, thus increasing its activity, in the hippocampus and anterior cingulate cortex suggesting that BDNF-TrkB signaling in these brain regions may be critical in mediating antidepressant effects (Rantamäki et al., 2007).”
From BDNF - a key transducer of antidepressant effects (2016) · cites this paper as Rantamäki et al., 2007
In the citing paper
“autophosphorylation of TrkB by antidepressants has also been reported by the group of Castren (Rantamaki et al. 2007; Saarelainen et al. 2003)”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2007
In the citing paper
“Other studies have found that antidepressants from a variety of chemical families (e.g., SSRIs, SNRIs, tricyclics, etc.) all increase activation of TrkB and its downstream effector CREB (140).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [140]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 4×
“Selected antidepressant doses have been routinely used in rodent models of behavioral despair (Porsolt et al, 1977; Wong et al, 2000; Drago et al, 2001; Weinstock et al, 2002; O’Leary et al, 2007).”
InfluentialNeurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“This FLX administration protocol has been previously shown to produce long-term alterations in neuroplasticity and animal behavior (Santarelli et al, 2003).”
InfluentialEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“Furthermore, val/met polymorphism in BDNF gene, which influences the activity-dependent BDNF release (Egan et al, 2003) has recently been associated with mood disorders in humans (Sklar et al, 2002; Lang et al, 2005).”
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 4×
“In addition, antidepressants block and accelerate the reversion of stress-induced downregulation in BDNF mRNA and protein, respectively (Nibuya et al, 1995; Xu et al, 2004).”
InfluentialBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Smith, M., Makino, S., Kvetnansky, R., & Post, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,440
Cited by
Items 201–300 of 348
Kennedy, S. H., Young, A. H., & Blier, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.048 · Cited by 20
Utilization of in situ ELISA method for examining Trk receptor phosphorylation in cultured cells
Antila, H., Autio, H., Turunen, L., Harju, K., Tammela, P., Wennerberg, K., Yli‐Kauhaluoma, J. T., Huttunen, H. J., Ċastrén, E., & Rantamäki, T. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.11.001 · Cited by 20
Self-citationRossetti, A. C., Paladini, M. S., Racagni, G., Riva, M. A., Cattaneo, A., & Molteni, R. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1298839 · Cited by 20
Mohandas, K., Rishikesh, R., Balan, Y. M., Deepti, A., Hosseini, S., Körte, M., & Sasidharan, B. C. P. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05238-0 · Cited by 19
Hansen, H. H., Rantamäki, T., Larsen, M. H., Woldbye, D. P. D., Mikkelsen, J. D., & Ċastrén, E. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9145-1 · Cited by 19
Self-citationPytka, K., Młyniec, K., Podkowa, K., Podkowa, A., Jakubczyk, M., Żmudzka, E., Lustyk, K., Sapa, J., & Filipek, B. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.026 · Cited by 19
Research Progress on BDNF and Depression
Qiu, Y., Zhu, L., Cai, W., & Zhu, L. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00193 · Cited by 19
Stress, mental disorder and ketamine as a novel, rapid acting treatment
Dutton, M., Can, A., Lagopoulos, J., & Hermens, D. F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.09.006 · Cited by 18
Moskaliuk, V. S., Kozhemyakina, R. V., Базовкина, Д. В., Terenina, E. E., Khomenko, T. M., Volcho, K. P., Salakhutdinov, N. F., Kulikov, A. V., Naumenko, V. S., & Kulikova, E. A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112667 · Cited by 17
Wu, Q., He, Q., Zhang, X., Chen, S., & Xue, X. (2024) · Aging and Disease · doi:10.14336/ad.2024.0834 · Cited by 17
Yaniv, S. P., Ben‐Shachar, D., & Klein, E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.006 · Cited by 17
Effects of Citalopram on Sutural and Calvarial Cell Processes
Durham, E. L., Jen, S., Wang, L., Nasworthy, J., Elsalanty, M. E., Weinberg, S. M., Yu, J. C.-K., & Cray, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139719 · Cited by 17
The keys to improving depression outcomes
Rizvi, S. J., & Kennedy, S. H. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.002 · Cited by 16
Межлумян, А. Г., Таллерова, А. В., Povarnina, P. Y., Тарасюк, А. В., Sazonova, N. M., Гудашева, Т. А., & Середенин, С. Б. (2022) · Pharmaceuticals · doi:10.3390/ph15030284 · Cited by 16
Dual Regulation of Spine-Specific and Synapse-to-Nucleus Signaling by PKCδ during Plasticity
Colgan, L. A., Parra-Bueno, P., Holman, H. L., Tu, X., Jain, A., Calubag, M. F., Misler, J. A., Gary, C., Oz, G., Suponitsky-Kroyter, I., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0208-22.2023 · Cited by 17
Casarotto, P. C., Santos, P., Lucas, G., Biojone, C., Pobbe, R. L. H., Vilela‐Costa, H. H., Joca, S. R. L., Guimarães, F. S., & Zangrossi, H. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.004 · Cited by 16
Alter, D., Beverley, J. A., Patel, R., Bolaños‐Guzmán, C. A., & Steiner, H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117715598 · Cited by 16
Kusuda, R., Ravanelli, M. I. B., Cadetti, F., Franciosi, A. C., Previdelli, K., Zanon, S., & Lucas, G. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.04.015 · Cited by 16
Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics
Sadée, W. (2023) · Molecules · doi:10.3390/molecules28176375 · Cited by 15
Reddy, B. R., Nukala, S. B., Das, T., Bhattacharya, D., Murthy, C. L. N., Kumar, A., Idris, M. M., & Chakravarty, S. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173170 · Cited by 15
Antidepressants are neuroprotective against nutrient deprivation stress in rat hippocampal neurons
Yang, D. C. H., Chen, M. J., & Russo‐Neustadt, A. A. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08187.x · Cited by 15
Sbrini, G., Brivio, P., Sangiovanni, E., Fumagalli, M., Racagni, G., Dell’Agli, M., & Calabrese, F. (2020) · Biomedicines · doi:10.3390/biomedicines8120544 · Cited by 15
Does Stress Elicit Depression? Evidence From Clinical and Preclinical Studies
Sickmann, H. M., Li, Y., Mørk, A., Sánchez, C., & Gulinello, M. E. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_292 · Cited by 14
Theilmann, W., Alitalo, O., Yorke, I., & Rantamäki, T. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.11.018 · Cited by 14
Self-citationGABAB receptor intracellular signaling: novel pathways for depressive disorder treatment?
Korczak, M., Kurowski, P. N., Leśniak, A., Grönbladh, A., Filipowska, A., & Bujalska‐Zadrożny, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173531 · Cited by 14
Regulating the Plasticity of Hippocampal Neurons via Electroacupuncture in Depression Model Mice
Wang, Y., Du, X., Duan, C., Wang, M., Zhu, Y., Wang, L., Hu, J. X., & Sun, Y. (2025) · Cell Proliferation · doi:10.1111/cpr.70057 · Cited by 13
Carboni, L., Rullo, L., Caputi, F. F., Stamatakos, S., Candeletti, S., & Romualdi, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214041 · Cited by 13
Bommaraju, S., Dhokne, M. D., Arun, E. V., Srinivasan, K., Sharma, S. S., & Datusalia, A. K. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110943 · Cited by 12
Lamoureux, L., Beverley, J. A., Marinelli, M., & Steiner, H. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100131 · Cited by 12
Yao, H., Wang, X., Chi, J., Chen, H., Liu, Y., Jiayi, Y., Yu, J., Ruan, Y., Xiang, X., Pi, J., et al. (2024) · Molecules · doi:10.3390/molecules29050964 · Cited by 12
Neurotrophic Factors and Antidepressant Action: Recent Advances
O’Leary, O. F., & Ċastrén, E. (2010) · Modern trends in psychiatry · doi:10.1159/000319514 · Cited by 13
Chronic fluoxetine dissociates contextual from auditory fear memory
Sanders, J., & Mayford, M. R. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.057 · Cited by 12
Esteban-Ortega, G. M., Torres-Campos, E., & Díaz‐Guerra, M. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07990-6 · Cited by 11
Linking Hypothermia and Altered Metabolism with TrkB Activation
Alitalo, O., González-Hernández, G., Rosenholm, M., Kohtala, P., Matsui, N., Müller, H. K., Theilmann, W., Klein, A. B., Kärkkäinen, O. K., Rozov, S. V., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00350 · Cited by 11
Self-citationVillalba, S., González, B., Junge, S., Bernardi, A., González, J., Fagúndez, C., Torterolo, P., Carrera, I., Urbano, F. J., & Bisagno, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020687 · Cited by 11
Domingos, L. B., Müller, H. K., da Silva, N. R., Filiou, M. D., Nielsen, A. L., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109870 · Cited by 11
Alitalo, O., Kohtala, S., Rosenholm, M., Saarreharju, R., González-Hernández, G., Sarparanta, M. P., Rozov, S. V., & Rantamäki, T. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110172 · Cited by 11
Self-citationPark, Y.-M., Lee, S., Lee, H., Kang, S., Min, J., & Chae, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060340 · Cited by 11
Neuroprotective roles of neurotrophic factors in depression
Groß, C., & Seroogy, K. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00007-0 · Cited by 11
McNerney, M. W., Kraybill, E. P., Narayanan, S., Mojabi, F. S., Venkataramanan, V., & Heath, A. M. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112323 · Cited by 9
Biojone, C., Cannarozzo, C., Seiffert, N., Diniz, C. R. A. F., Brunello, C. A., Ċastrén, E., & Casarotto, P. C. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01438-1 · Cited by 9
Vierci, G., Oliveira, C. S., Perera, L. R., Bornia, N., Leal, R. B., & Rossi, F. (2012) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2012.10.003 · Cited by 9
Theilmann, W., Rosenholm, M., Hampel, P., Löscher, W., & Rantamäki, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235046 · Cited by 9
Self-citationWinkel, F., Voigt, M. B., Didio, G., Matéo, S., Jetsonen, E., Pou, M. L., Steinzeig, A., Ryazantseva, M., Harkki, J., Englund, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.27.063503 · Cited by 9
Hasanabadi, A. J., Beirami, E., Kamaei, M., & Esfahani, D. E. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112517 · Cited by 8
Li, J., Liu, L., Sun, S., Liu, C., & Yin, P. (2026) · Medicine · doi:10.1097/md.0000000000046851 · Cited by 7
Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21
Laukkanen, L., Diniz, C. R. A. F., Foulquier, S., Prickaerts, J., Ċastrén, E., & Casarotto, P. C. (2021) · Pharmaceuticals · doi:10.3390/ph14080773 · Cited by 7
TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine
Fred, S. M., Moliner, R., Antila, H., Engelhardt, K., Schlüter, O. M., Casarotto, P. C., & Ċastrén, E. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15952 · Cited by 7
Neurotrophic Factors and Dendritic Spines
Halbach, O. V. B. U. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-36159-3_5 · Cited by 7
Han, M., Liu, G., Guo, J., Yu, S., & Huang, J. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.179066 · Cited by 7
the role of antidepressant treatments on cognitive deficits: a review of recent literature
Francomano, A., Fucà, L., Placa, M. L., LA BARBERA, D., & Bonanno, B. (2011) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 6
Zhang, Y., Shi, J., Li, J., Liu, R., Yu, Y., & Xu, Y. (2017) · PubMed · Cited by 5
Image-Based High-Content Screening in Drug Discovery
Götte, M., & Gabriel, D. (2011) · InTech eBooks · doi:10.5772/27338 · Cited by 5
Иродионовна, В. Т., Ахапкин, Р. В., & Aleksandrovsky, Y. A. (2019) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1107 · Cited by 5
Potential of Heterogeneous Compounds as Antidepressants: A Narrative Review
Hu, G., Zhang, M., Wang, Y., Yu, M., & Zhou, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213776 · Cited by 5
Antidepressant drugs act by directly binding to TRKB neurotrophin receptorsPreprint
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V. D., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/757989 · Cited by 5
Glennon, R. A., & Iversen, L. L. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc101.pub3 · Cited by 5
Poggini, S., Bon, G. M., Albanese, N. C., Karpova, N. N., Ċastrén, E., D’Andrea, I., & Branchi, I. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.145 · Cited by 4
Gohar, A., Ali, G., Rashid, U., Rauf, K., Arif, M., Khan, M. S., Alkahraman, Y. M., & Sewell, R. D. E. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s407229 · Cited by 4
Neurochemical Signaling in Depression: Impact of Target-Based Pharmaceuticals
Sharma, B., & Khushboo (2022) · Current Drug Therapy · doi:10.2174/1574885517666220817122840 · Cited by 4
Bermúdez, C. M. (2012) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60075-5 · Cited by 4
Neuroprotective roles of neurotrophic growth factors in mood disorders
Jiang, C. S., & Salton, S. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00010-0 · Cited by 4
Müller, L. G., Biojone, C., Sales, A. J., Betti, A. H., Herzfeldt, V., Joca, S. R. L., & Rates, S. M. K. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000534 · Cited by 4
Depression and antidepressant action—from molecules to networks
Rantamäki, T., & Yalçın, İ. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03042-6 · Cited by 4
Self-citationLi, Z., Mu, X., Wang, Q., Zhou, Z., Wang, Z., Wang, Y., Liu, Q., Lin, W., Qin, F., Pan, H., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70101 · Cited by 3
TrkB/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine
Arefin, A., Kim, J., Chakraborty, M. P., Martinelli, S., Bai, B., Lee, F. S., & Levitz, J. (2026) · Science Advances · doi:10.1126/sciadv.aec1444 · Cited by 3
Faron‐Górecka, A., Kuśmider, M., Gruca, P., Pabian, P., Korlatowicz, A., Solich, J., Kolasa, M., & Dziedzicka‐Wasylewska, M. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147948 · Cited by 3
Anokhin, P. K., Veretinskaya, A. G., Pavshintsev, V. V., & Shamakina, I. Y. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911911154 · Cited by 3
Neurophysiological mechanisms of plasticity induced in adult brain
Popova, D. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 3
Levy, M. J. F. (2017) · theses.fr (ABES) · doi:10.70675/be792343za725z4b2czb8c5z8a26a8113d23 · Cited by 3
Glennon, R. A., & Iversen, L. L. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc101.pub2 · Cited by 3
Nguyen, H. D., Vu, G. H., & Kim, W. (2024) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2024.100128 · Cited by 2
Raslan, H. A., Michel, H. E., Menze, E. T., & El-Gazar, A. A. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10271-w · Cited by 2
Ballesio, A., & Rosa, P. L. (2026) · Current Sleep Medicine Reports · doi:10.1007/s40675-026-00372-0 · Cited by 2
Zoladz, P. R., Riggenbach, M. R., Weiser, J. N., Hipskind, J. J., Wireman, L. E., Hess, K. L., Duffy, T. J., Handel, J. K., Kaschalk, M. G., Reneau, K. E., et al. (2022) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2022.125012 · Cited by 2
Fava, M., & Papakostas, G. I. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50045-7 · Cited by 2
Li, Q. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511729935.003 · Cited by 2
Anokhin, P. K., Veretinskaya, A. G., Pavshintsev, V. V., & Shamakina, I. Y. (2020) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-020-00974-3 · Cited by 2
Neurotrophins and neuronal plasticity in the action of antidepressants and morphine
Sairanen, M. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 2
Leikas, J. V. (2021) · UEF eRepo (University of Eastern Finland) · Cited by 2
Pinhasov, A., Michaelevski, I., Koman, I. E., & Nesher, E. (2016) · Current topics in neurotoxicity · doi:10.1007/978-3-319-35135-3_43 · Cited by 1
Palma, A., & Brugnoli, R. (2007) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 1
Suicidalité sous antidépresseurs : aspects cliniques et étude cas-témoin pharmacogénétique
Voegeli, G. (2015) · Cited by 1
Таллерова, А. В., Межлумян, А. Г., Povarnina, P. Y., Антипова, Т. А., Логвинов, И. О., Гудашева, Т. А., & Середенин, С. Б. (2020) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-020-02217-8 · Cited by 1
Visuosocial Preference Memory, but Not Avoidance Memory, Requires PLCγ1 in the CA2 Hippocampus
Kim, S., Kim, J., Park, Y. M., Suh, P., & Lee, C. J. (2022) · Experimental Neurobiology · doi:10.5607/en22033 · Cited by 1
Chapter 14. Citalopram and Escitalopram
Shelton, R. C. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as14 · Cited by 1
Neurotrophic Factors as Novel Therapeutic Targets
Skaper, S. D. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse458 · Cited by 1
Henningsson, S. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Activation of the TrkB Neurotrophin Receptor by Antidepressant Drugs
Antila, H. (2016) · Helda - University of Helsinki Institutional Repository · Cited by 1
GPCR and RTK Regulation in Neurons: The Impact of Stress on GPCR and RTK signalling and Crosstalk
Gondora, N. (2020) · UWSpace (University of Waterloo) · Cited by 1
Stil, A. (2011) · theses.fr (ABES) · doi:10.70675/0a615ab8z65c9z451az9b08zc423d6cb7d77 · Cited by 1
Antila, H. (2012) · Helda - University of Helsinki Institutional Repository
The stress factor FKBP51 orchestrates pathways targeted by psycho-active drugs
Gassen, N. C. (2013) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16381
Neidhardt, A. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8097
Mokhber, N., & Talaeı, A. (2007)
Suavinha, A. C. D. R. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2014.tde-24062014-092102
Vagus nerve stimulation for epilepsy and depression : mechanism of action and stimulation parameters
Grimonprez, A. (2015) · Ghent University Academic Bibliography (Ghent University)
Gray, V. (2013) · UC Research Repository (University of Canterbury) · doi:10.26021/8445
Metadata
- Authors
- Rantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E.
- Affiliations
- University of Helsinki (FI)
- GlaxoSmithKline (Italy) (IT)
- NYU Langone Health (US)
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-02-21
- Volume
- 32
- Issue
- 10
- Pages
- 2152-2162
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2064468814
- Cited by
- 305
- References
- 75
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 18 · 2023: 17 · 2022: 15 · 2021: 15 · 2020: 18 · 2019: 18 · 2018: 14 · 2017: 20 · 2016: 13 · 2015: 16 · 2014: 15 · 2013: 18 · 2012: 20
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Iris (University of Trento) (submittedVersion)
- Funders
- GlaxoSmithKline
- Academy of Finland
- Suomen Kulttuurirahasto
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressants, TrkB receptor, brain-derived neurotrophic factor, phospholipase C-gamma1, CREB, monoamine transporters, citalopram, reboxetine, serotonin depletion, norepinephrine depletion, anterior cingulate cortex, hippocampus, forced swim test, monoamine signaling
- MeSH terms
- Reboxetine, Animals, Antidepressive Agents, Binding Sites, Brain, Brain Chemistry, Depressive Disorder, Gyrus Cinguli, Hippocampus, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Morpholines, Phosphorylation, Citalopram, Signal Transduction, Up-Regulation, Cyclic AMP Response Element-Binding Protein, Selective Serotonin Reuptake Inhibitors, Adrenergic Uptake Inhibitors, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mice, Phospholipase C gamma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.